Abstract
Platelet-activating factor (PAF) is a naturally occurring phospholipid that acts as a potent mediator of inflammation and bronchoconstriction. Since mucus secretion accompanies many pulmonary-allergic reactions, we examined the effect of PAF on respiratory glycoconjugate (RGC) release from human airways in vitro. PAF, in concentrations of 5 to 100 ng/ml, induced a specific, dose-dependent release of [3H]RGC from human airways in vitro (range of 15% to 120% increase above control, p less than 0.001; n = 8). Time-course studies revealed that RGC release reached its peak level by 60 minutes, and by the end of 4 hours, decreased almost to the baseline level, suggesting a stimulatory effect on secretion rather than synthesis. PAF analog, RO 19-3704, which is a PAF-receptor antagonist, inhibited RGC secretion mediated by PAF in a dose-dependent manner with an inhibitory concentration of 50% of 70 ng/ml. BW 755C and nordihydroguaiaretic acid, but not indomethacin, inhibited RGC release by PAF. LY 171883, a specific leukotriene D4-receptor antagonist, totally inhibited the release of RGC by PAF. Similar results were observed with FPL 55712. PAF-treated airways generated peptidoleukotrienes significantly above control airways in associa...Continue Reading
References
Jun 28, 1979·Nature·M ChignardJ Benveniste
Feb 1, 1988·The American Review of Respiratory Disease·J D LundgrenJ Shelhamer
Jan 1, 1987·Experimental Lung Research·K B AdlerA F Welton
Apr 25, 1985·Biochimica Et Biophysica Acta·S K Goswami, R M Gould
Dec 1, 1972·The Journal of Experimental Medicine·J BenvenisteC G Cochrane
Jun 7, 1974·Nature·J Benveniste
Apr 1, 1970·Lipids·D C Zimmerman, B A Vick
Jul 1, 1984·Prostaglandins·Z MaromM Kaliner
Jan 1, 1984·Experimental Lung Research·J H ShelhamerM Kaliner
Jul 1, 1983·The Journal of Clinical Investigation·Z MaromM Kaliner
Feb 1, 1983·Prostaglandins·S J ColesR A Lewis
Feb 1, 1984·In Vitro·C E SnyderA Herp
Jun 1, 1981·The Journal of Clinical Investigation·Z MaromM Kaliner
Dec 1, 1980·European Journal of Clinical Investigation·B ArnouxJ Benveniste
May 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·F HirataJ Axelrod
Jul 25, 1980·European Journal of Pharmacology·B B VargaftigJ Benveniste
Dec 1, 1980·The Journal of Clinical Investigation·J H ShelhamerM Kaliner
Citations
May 1, 1996·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·L KahhakJ Benveniste
Jan 1, 1995·Lung·T WuJ H Shelhamer
Jan 1, 1991·Annals of the New York Academy of Sciences·P J Barnes
Feb 1, 1992·American Journal of Respiratory Cell and Molecular Biology·R D RievesJ H Shelhamer
May 1, 1992·American Journal of Respiratory Cell and Molecular Biology·K B AdlerW C Glasgow
Feb 22, 2008·Journal of Occupational Medicine and Toxicology·Rene SchmidtUlrich Wagner
Nov 1, 1991·Experimental Lung Research·T WuJ H Shelhamer
Mar 20, 1999·Chest·C KishiokaB K Rubin
May 9, 2008·Pulmonary Pharmacology & Therapeutics·Brendan J Canning, Yangling Chou
Jun 1, 1992·Pulmonary Pharmacology·J D Lundgren, J N Baraniuk
Jun 1, 1991·The Journal of Allergy and Clinical Immunology·J TamaokiT Takizawa
Jan 1, 1996·Acta Oto-laryngologica·J LinS K Juhn
Jan 1, 1994·Experimental Lung Research·S GoswamiZ Marom
Mar 1, 1996·Chest·L G RochelleK B Adler
Sep 4, 2015·Physiological Reviews·Jonathan H Widdicombe, Jeffrey J Wine
Feb 13, 2001·American Journal of Physiology. Lung Cellular and Molecular Physiology·M KomoriN Hara
Jan 1, 1991·Pulmonary Pharmacology·J N Baraniuk